Abingdon Health Plc
Market Cap
$15.28M
P/E Ratio
-7.89
EPS
$-0.01
Dividend Yield
0.00%
52-Week Range
$5.10 — $9.00
Volume
336.74K
Avg Volume
180.03K
Beta
0.25
P/E (TTM)
-7.89
Forward P/E
—
PEG Ratio
0.26
P/S (TTM)
1.61
P/B (TTM)
4.96
P/FCF
—
EV/EBITDA
—
EV/Sales
—
ROE (TTM)
-0.58%
ROA (TTM)
-0.37%
ROIC
—
Gross Margin
0.37%
Operating Margin
-0.46%
Net Margin
—
Debt/Equity
0.19
Current Ratio
1.76
EPS Growth (YoY)
—
Revenue Growth (YoY)
—
EPS Growth (3Y)
+0.09%
EPS Growth (5Y)
-0.16%
Sales Growth (3Y)
+0.44%
Sales Growth (5Y)
+0.36%
EPS Est (This Year)
$-0.00
EPS Est (Next Year)
$0.00
Dividend Yield
—
Annual Dividend
—
Payout Ratio
—
Frequency
—
Ex-Dividend Date
—
Cash/Share
$0.01
Institutional %
—
Inst. Net Change
—
Insider Net Shares (90d)
—
Outstanding Shares
193.63M
Float
184.40M
Free Float %
95.23%
Sector
Healthcare
Industry
Medical - Diagnostics & Research
Country
GB
Exchange
LSE
IPO Date
2020-12-15
Employees
113
CEO
Christopher William Hand
Index Membership
—
Website
https://www.abingdonhealth.com
Abingdon Health Plc (ABDX.L) is a healthcare company in the medical - diagnostics & research industry listed on the LSE. With a market capitalization of $15.28M, a P/E ratio of -7.89, ABDX.L is tracked by stockscreenr alongside 25,000+ other tickers. Use the free stock screener to compare ABDX.L against other stocks using dozens of fundamental and technical filters.
Abingdon Health Plc (ABDX.L) has a trailing twelve-month (TTM) P/E ratio of -7.89. This is below the market average, which may suggest the stock is undervalued or has lower growth expectations. The P/E ratio measures how much investors are willing to pay per dollar of earnings.
No, Abingdon Health Plc (ABDX.L) does not currently pay a regular dividend. The company may be reinvesting profits into growth, research, or debt reduction instead of returning cash to shareholders through dividends.
Abingdon Health Plc (ABDX.L) has a market capitalization of $15.28 million, classifying it as a micro-cap company. Market cap is calculated by multiplying the current share price by the total number of outstanding shares.